FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Padagis US LLC)

View source ↗

Summary

FDA approves Padagis US LLC Loteprednol etabonate ophthalmic suspension under an original ANDA application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Ocular Inflammation
• Postoperative Ocular Inflammation

Drugs mentioned

• Loteprednol etabonate ophthalmic suspension (Loteprednol etabonate)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)